Sodium-Glucose Cotransporter 2 Inhibitor

This page covers all Sodium-Glucose Cotransporter 2 Inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sodium/glucose cotransporter 2.

Targets

Sodium/glucose cotransporter 2

Marketed (2)

• Farxiga · AstraZeneca · Immunology · 6300
  Farxiga works by blocking the SGLT2 protein in the kidneys, reducing glucose reabsorption and promoting its excretion in the urine.
• Invokana · Johnson & Johnson · Metabolic · 800
  Invokana works by blocking the SGLT2 protein in the kidneys to reduce glucose reabsorption.

Patent intelligence

• sodium glucose cotransporter 2 inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates